Sr. Accountant-SEC Reporting & Technical Accounting

## Who We Are: Neurocrine Biosciences is a leading biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering, developing and commercializing life-changing treatments for patients with under-addressed neurological, psychiatric, endocrine and immunological disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, hyperphagia in patients with Prader-Willi syndrome, endometriosis\* and uterine fibroids\*, as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For more than three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders, because you deserve brave science. For more information, visit [neurocrine.com](https://c212.net/c/link/?t=0&l=en&o=4450443-1&h=3502828688&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4252873-1%26h%3D4039787179%26u%3Dhttps%253A%252F%252Fwww.neurocrine.com%252F%26a%3Dneurocrine.com&a=neurocrine.com), and follow the company on [LinkedIn](https://c212.net/c/link/?t=0&l=en&o=4450443-1&h=884458364&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4252873-1%26h%3D928986078%26u%3Dhttps%253A%252F%252Fwww.linkedin.com%252Fcompany%252Fneurocrine-biosciences%26a%3DLinkedIn&a=LinkedIn), [X](https://c212.net/c/link/?t=0&l=en&o=4450443-1&h=1730331693&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4252873-1%26h%3D3255611529%26u%3Dhttps%253A%252F%252Ftwitter.com%252Fneurocrine%26a%3DX%2B%28formerly%2BTwitter%29&a=X), [Facebook](https://c212.net/c/link/?t=0&l=en&o=4450443-1&h=3526407131&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4252873-1%26h%3D1536396415%26u%3Dhttps%253A%252F%252Fwww.facebook.com%252FNeurocrine%26a%3DFacebook&a=Facebook) and [YouTube](https://www.youtube.com/@NeurocrineBiosciencesInc). (*\*in collaboration with AbbVie*) ## About the Role: We are seeking an experienced Senior Accountant to play a key role in corporate accounting, financial reporting, and compliance. This position owns critical components of stock-based compensation accounting and SEC reporting processes, contributes to SOX 404 compliance, and serves as a subject matter resource within the accounting function. This role is designed for an experienced professional who operates with a high degree of independence, contributes to complex initiatives, and influences process improvements across the organization. \_ ## Your Contributions (include, but are not limited to): **Stock-Based Compensation** - Own end-to-end accounting for stock-based compensation under ASC 718, including expense recognition, forfeitures, modifications, and settlements. - Prepare, review, and analyze equity compensation schedules and roll forwards; ensure accuracy and completeness for period-end close. - Serve as a subject matter resource for equity compensation, providing guidance to cross-functional partners (HR, Legal, Payroll). - Lead the preparation and review of equity-related disclosures for SEC filings, including footnotes and supporting documentation. - Identify and implement process improvements and automation opportunities within equity accounting workflows. **SEC Reporting & Workiva Support** - Prepare and review assigned sections of quarterly and annual SEC filings (Forms 10-Q, 10-K), ensuring accuracy, consistency, and compliance. - Own tie-out process for assigned areas, ensuring alignment between financial statements, disclosures, and supporting schedules. - Maintain and enhance Workiva processes, including roll forwards, document integrity, tagging support, and version control. - Partner with internal stakeholders to improve reporti…